Medicare does not cover GLP-1 medications when prescribed for weight loss alone (CMS rules), though Medicare Part D plans may cover Ozempic, Mounjaro, or Wegovy when prescribed for type 2 diabetes or established cardiovascular disease
When diabetes is undetected or inadequately treated, people with diabetes are at risk of serious and life-threatening complications, such as heart attack, stroke, kidney failure, blindness, and lower-limb amputation
getting too much blue light disrupts your natural melatonin production, making it more difficult to sleep and causing sleep loss, which dramatically affects cognition
doi:10.1038/s41416-024-02674-y
The Kings Fund (2025) estimates that around 1.4 million people are accessing these medications privately from online pharmacies without medical supervision
Maybe you've heard of Wegovy too